Skip to content

Company
Pipeline
For Investors
Contact

Company
Pipeline
For Investors
Contact

Press Releases

Choose Year
Search Press Releases

Found 269 Results

October 6, 2016

Relmada Therapeutics to Present at the 15th Annual BIO Investor Forum

September 28, 2016

Relmada Therapeutics’ Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston

September 22, 2016

Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference

September 20, 2016

Relmada Therapeutics to Present at the 2016 Aegis Growth Conference

September 14, 2016

Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern

September 12, 2016

Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team

September 7, 2016

Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

July 6, 2016

Relmada Therapeutics Secures First European Patent Covering LevoCap ER

June 27, 2016

Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression

June 7, 2016

Relmada Therapeutics’ d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia

«...17 181920 21 22...»

IR Contact

Brian Ritchie
LifeSci Advisors, LLC

+1 (212) 915-2578
britchie@lifesciadvisors.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy^*

Unsubscribe

Loading...

Company

Pipeline
Overview
NDV-01
Speranolone

For Investors
Summary
News
Events
SEC Filings
Corporate Governance
Stock Information

Contact

info@relmada.com

+1 (786) 629-1376

©2026 Relmada Therapeutics, Inc.

Privacy Policy
Terms of Use

Scroll to Top